Bristol Myers raises 2026 revenue forecast, lowers EPS due to charge
By Deena BeasleyOct 29 (Reuters) – Bristol Myers Squibb raised its full-year revenue forecast on Thursday, citing strong sales of its newer medicines, but lowered its 2026 earnings per share projection due to a hefty acquisition-related charge.The US drugmaker said it now expects 2026 adjusted...

